These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers. Vaidyanathan S; Valencia J; Kemp C; Zhao C; Yeh CM; Bizot MN; Denouel J; Dieterich HA; Dole WP Int J Clin Pract; 2006 Nov; 60(11):1343-56. PubMed ID: 17073832 [TBL] [Abstract][Full Text] [Related]
7. Interaction of the renin inhibitor aliskiren with the SARS-CoV-2 main protease: a molecular docking study. Vergoten G; Bailly C J Biomol Struct Dyn; 2022; 40(23):12714-12722. PubMed ID: 34514971 [TBL] [Abstract][Full Text] [Related]
8. Changes in Phenylpropanoid and Trichothecene Production by Fusarium culmorum and F. graminearum Sensu Stricto via Exposure to Flavonoids. Bilska K; Stuper-Szablewska K; Kulik T; Buśko M; Załuski D; Jurczak S; Perkowski J Toxins (Basel); 2018 Mar; 10(3):. PubMed ID: 29510600 [TBL] [Abstract][Full Text] [Related]
10. Hypouricemic action of selected flavonoids in mice: structure-activity relationships. Mo SF; Zhou F; Lv YZ; Hu QH; Zhang DM; Kong LD Biol Pharm Bull; 2007 Aug; 30(8):1551-6. PubMed ID: 17666819 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of xanthine oxidase-catalyzed xanthine and 6-mercaptopurine oxidation by luteolin, naringenin, myricetin, ampelopsin and their conjugated metabolites. Balázs O; Dombi Á; Zsidó BZ; Hetényi C; Valentová K; Vida RG; Poór M Biomed Pharmacother; 2023 Nov; 167():115548. PubMed ID: 37734263 [TBL] [Abstract][Full Text] [Related]
12. Inhibition characteristics and mechanism of tyrosinase using five citrus flavonoids: A spectroscopic and molecular dynamics simulation study. Li W; Tian H; Guo F; Wu Y J Food Biochem; 2022 Dec; 46(12):e14484. PubMed ID: 36239431 [TBL] [Abstract][Full Text] [Related]
13. Conformational Properties and Energetic Analysis of Aliskiren in Solution and Receptor Site. Politi A; Leonis G; Tzoupis H; Ntountaniotis D; Papadopoulos MG; Grdadolnik SG; Mavromoustakos T Mol Inform; 2011 Dec; 30(11-12):973-85. PubMed ID: 27468152 [TBL] [Abstract][Full Text] [Related]
14. Aliskiren, a novel orally effective renin inhibitor, exhibits similar pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects. Vaidyanathan S; Jermany J; Yeh C; Bizot MN; Camisasca R Br J Clin Pharmacol; 2006 Dec; 62(6):690-8. PubMed ID: 17118124 [TBL] [Abstract][Full Text] [Related]
15. Dietary flavonoid sources in Australian adults. Somerset SM; Johannot L Nutr Cancer; 2008; 60(4):442-9. PubMed ID: 18584477 [TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of the flavonoids hesperetin, naringenin and quercetin in human subjects following their habitual diets, and diets high or low in fruit and vegetables. Erlund I; Silaste ML; Alfthan G; Rantala M; Kesäniemi YA; Aro A Eur J Clin Nutr; 2002 Sep; 56(9):891-8. PubMed ID: 12209378 [TBL] [Abstract][Full Text] [Related]
17. Greater apparent absorption of flavonoids is associated with lesser human fecal flavonoid disappearance rates. Simons AL; Renouf M; Murphy PA; Hendrich S J Agric Food Chem; 2010 Jan; 58(1):141-7. PubMed ID: 19921837 [TBL] [Abstract][Full Text] [Related]
19. Protein kinase A-dependent insulinotropic effect of selected flavonoids. Hameed A; Ashraf S; Israr Khan M; Hafizur RM; Ul-Haq Z Int J Biol Macromol; 2018 Nov; 119():149-156. PubMed ID: 30003913 [TBL] [Abstract][Full Text] [Related]
20. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with allopurinol, celecoxib and cimetidine in healthy subjects. Ayalasomayajula S; Tchaloyan S; Yeh CM; Bizot MN; Dieterich HA; Howard D; Dole WP Curr Med Res Opin; 2008 Mar; 24(3):717-26. PubMed ID: 18234150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]